Search

Elizabeth A. Burkhart

Examiner (ID: 12400, Phone: (571)272-6647 , Office: P/1715 )

Most Active Art Unit
1715
Art Unit(s)
1762, 1715, 1792
Total Applications
919
Issued Applications
503
Pending Applications
11
Abandoned Applications
404

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5304381 [patent_doc_number] => 20090299033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules' [patent_app_type] => utility [patent_app_number] => 12/485998 [patent_app_country] => US [patent_app_date] => 2009-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 23073 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20090299033.pdf [firstpage_image] =>[orig_patent_app_number] => 12485998 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/485998
Methods and compositions for F-18 labeling of proteins, peptides and other molecules Jun 16, 2009 Issued
Array ( [id] => 9273052 [patent_doc_number] => 08636978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Cyclized NGR peptide compounds, compositions, and methods of their use' [patent_app_type] => utility [patent_app_number] => 13/000543 [patent_app_country] => US [patent_app_date] => 2009-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 6612 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13000543 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/000543
Cyclized NGR peptide compounds, compositions, and methods of their use Jun 14, 2009 Issued
Array ( [id] => 8490274 [patent_doc_number] => 20120289681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'CONJUGATES OF CELL-PENETRATING PEPTIDES AND PHOSPHORESCENT METALLOPORPHYRINS FOR INTRACELLULAR OXYGEN MEASUREMENT' [patent_app_type] => utility [patent_app_number] => 13/143309 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8117 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13143309 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/143309
CONJUGATES OF CELL-PENETRATING PEPTIDES AND PHOSPHORESCENT METALLOPORPHYRINS FOR INTRACELLULAR OXYGEN MEASUREMENT Jun 7, 2009 Abandoned
Array ( [id] => 5403469 [patent_doc_number] => 20090238783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'TREATMENT AND COMPOSITION FOR ACHIEVING SKIN ANTI-AGING BENEFITS BY CORNEUM PROTEASE ACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/479079 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8605 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20090238783.pdf [firstpage_image] =>[orig_patent_app_number] => 12479079 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/479079
Treatment and composition for achieving skin anti-aging benefits by corneum protease activation Jun 4, 2009 Issued
Array ( [id] => 6646164 [patent_doc_number] => 20100228012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'PENDANT FATTY ACID IMAGING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/478531 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9776 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20100228012.pdf [firstpage_image] =>[orig_patent_app_number] => 12478531 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/478531
PENDANT FATTY ACID IMAGING AGENTS Jun 3, 2009 Abandoned
Array ( [id] => 5495299 [patent_doc_number] => 20090263327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'MINIMALLY INVASIVE PHYSIOLOGICAL FUNCTION MONITORING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/476169 [patent_app_country] => US [patent_app_date] => 2009-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10886 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263327.pdf [firstpage_image] =>[orig_patent_app_number] => 12476169 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/476169
MINIMALLY INVASIVE PHYSIOLOGICAL FUNCTION MONITORING AGENTS May 31, 2009 Abandoned
Array ( [id] => 6355275 [patent_doc_number] => 20100022449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'RECEPTOR-AVID EXOGENOUS OPTICAL CONTRAST AND THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/470310 [patent_app_country] => US [patent_app_date] => 2009-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19596 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022449.pdf [firstpage_image] =>[orig_patent_app_number] => 12470310 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/470310
RECEPTOR-AVID EXOGENOUS OPTICAL CONTRAST AND THERAPEUTIC AGENTS May 20, 2009 Abandoned
Array ( [id] => 8841064 [patent_doc_number] => 20130136691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'GASTRIN RELEASING PEPTIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/993620 [patent_app_country] => US [patent_app_date] => 2009-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 95 [patent_figures_cnt] => 95 [patent_no_of_words] => 111278 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993620 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/993620
GASTRIN RELEASING PEPTIDE COMPOUNDS May 18, 2009 Abandoned
Array ( [id] => 6006994 [patent_doc_number] => 20110059025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'IN VIVO IMAGING' [patent_app_type] => utility [patent_app_number] => 12/990217 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12737 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059025.pdf [firstpage_image] =>[orig_patent_app_number] => 12990217 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/990217
IN VIVO IMAGING Apr 30, 2009 Abandoned
Array ( [id] => 9957378 [patent_doc_number] => 09005577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Substrate based PET imaging agents' [patent_app_type] => utility [patent_app_number] => 12/433211 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27120 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12433211 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/433211
Substrate based PET imaging agents Apr 29, 2009 Issued
Array ( [id] => 5472964 [patent_doc_number] => 20090246130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules' [patent_app_type] => utility [patent_app_number] => 12/433212 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 52931 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246130.pdf [firstpage_image] =>[orig_patent_app_number] => 12433212 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/433212
Methods and compositions for F-18 labeling of proteins, peptides and other molecules Apr 29, 2009 Issued
Array ( [id] => 6367457 [patent_doc_number] => 20100074844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Cyclopeptides Containing RGD Mimetics As Imaging Markers For Integrins' [patent_app_type] => utility [patent_app_number] => 12/433258 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23102 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074844.pdf [firstpage_image] =>[orig_patent_app_number] => 12433258 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/433258
Cyclopeptides containing RGD mimetics as imaging markers for integrins Apr 29, 2009 Issued
Array ( [id] => 9388777 [patent_doc_number] => 08685371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Agents for detecting and imaging cell death' [patent_app_type] => utility [patent_app_number] => 12/989310 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 16235 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12989310 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989310
Agents for detecting and imaging cell death Apr 28, 2009 Issued
Array ( [id] => 7818747 [patent_doc_number] => 20120065367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'Radioactively Labeled Substance' [patent_app_type] => utility [patent_app_number] => 13/266249 [patent_app_country] => US [patent_app_date] => 2009-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13332 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065367.pdf [firstpage_image] =>[orig_patent_app_number] => 13266249 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/266249
Radioactively Labeled Substance Apr 27, 2009 Abandoned
Array ( [id] => 6235005 [patent_doc_number] => 20100266709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Compositions and Methods for Treating Burns' [patent_app_type] => utility [patent_app_number] => 12/429169 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21031 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266709.pdf [firstpage_image] =>[orig_patent_app_number] => 12429169 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/429169
Compositions and Methods for Treating Burns Apr 22, 2009 Abandoned
Array ( [id] => 5551775 [patent_doc_number] => 20090285761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Renal Function Analysis Method and Apparatus' [patent_app_type] => utility [patent_app_number] => 12/425827 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11289 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285761.pdf [firstpage_image] =>[orig_patent_app_number] => 12425827 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/425827
Renal Function Analysis Method and Apparatus Apr 16, 2009 Abandoned
Array ( [id] => 8577249 [patent_doc_number] => 08343458 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Probes for in vivo targeting of active cysteine proteases' [patent_app_type] => utility [patent_app_number] => 12/418116 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 13 [patent_no_of_words] => 15590 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12418116 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/418116
Probes for in vivo targeting of active cysteine proteases Apr 2, 2009 Issued
Array ( [id] => 5534433 [patent_doc_number] => 20090234221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'RESPONSIVE PARAMAGNETIC MRI CONTRAST AGENTS' [patent_app_type] => utility [patent_app_number] => 12/418155 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9734 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20090234221.pdf [firstpage_image] =>[orig_patent_app_number] => 12418155 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/418155
Responsive paramagnetic MRI contrast agents Apr 2, 2009 Issued
Array ( [id] => 6270205 [patent_doc_number] => 20100254912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Gadolinium containing prussian blue nanoparticles as nontoxic MRI contrast agents having high relaxivity' [patent_app_type] => utility [patent_app_number] => 12/384391 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6221 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254912.pdf [firstpage_image] =>[orig_patent_app_number] => 12384391 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/384391
Gadolinium containing prussian blue nanoparticles as nontoxic MRI contrast agents having high relaxivity Apr 2, 2009 Issued
Array ( [id] => 6070055 [patent_doc_number] => 20110044905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'OXYTOCIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 12/933858 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5651 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044905.pdf [firstpage_image] =>[orig_patent_app_number] => 12933858 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/933858
Oxytocin analogues Mar 29, 2009 Issued
Menu